Development in the atrioventricular canal of the embryonic heart is characterized by an endothelial-mesenchymal cell transformation of a subpopulation of endothelial cells. These cells change phenotype to become invasive mesenchymal cells and are the earliest progenitors of valve and septal structures in the heart. Through use of collagen gel cultures of embryonic chicken material, we and others showed that the transformation process is stimulated by a signal from the myocardium and is both regionally and temporally specific. Preliminary studies had identified a growth factor, TGFbeta, as a component of the transformation process. During the previous grant period we showed TGFbeta3, among the members of the TGFbeta family, to have an appropriate distribution within the heart. Further, reduction of TGFbeta3 mRNA levels by treating heart explants with modified antisense oligonucleotides confirmed a direct role for this molecule in the avian heart. We have also identified an mRNA that may hybridize to TGFbeta3 encoding transcripts within the heart. This antisense RNA has a distribution and appearance consistent with a role in regulating TGFbeta3 message translation. Additional studies were performed to begin to address the process of cell transformation by identifying signal transduction and gene expression in the target endothelial tissue. Continuing studies are proposed here to explore cell transformation in the heart and the regulation of TGFbeta3 in this process.
The specific aims of the proposal are to: l) Analyze TGFbeta3 message and protein production during cushion tissue formation. 2) Characterize antisense TGFbeta3 mRNA in the heart and, if appropriate, its protein product. 3) Characterize the activation signals which regulate antisense TGFbeta3 transcription. 4) Examine expression of signal transduction molecules and additional molecules identified within this SCOR which can be directly related to valve formation or related morphogenetic processes in the embryonic heart. These studies will define the role of TGFbeta3 and its regulation in the differentiation of cardiac valvular and septal mesenchyme. The goal of this work is to understand the molecular signals involved in this process of induced phenotypic change. An understanding of these processes will provide both basic developmental principles and identify candidate genes and interactions involved in congenital heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL042266-09
Application #
6109980
Study Section
Project Start
1998-01-30
Project End
2000-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Wang, Qinchuan; Lin, Jenny Li-Chun; Erives, Albert J et al. (2014) New insights into the roles of Xin repeat-containing proteins in cardiac development, function, and disease. Int Rev Cell Mol Biol 310:89-128
Jongewaard, Ian N; Lauer, Ronald M; Behrendt, Douglas A et al. (2002) Beta 1 integrin activation mediates adhesive differences between trisomy 21 and non-trisomic fibroblasts on type VI collagen. Am J Med Genet 109:298-305
Wang, Qin; Li-Chun Lin, Jenny; Jung-Ching Lin, Jim (2002) A novel TCTG(G/C) direct repeat and an A/T-rich HMG2-binding site control the expression of the rat cardiac troponin T gene. J Mol Cell Cardiol 34:1667-79
Camenisch, Todd D; Molin, Daniel G M; Person, Anthony et al. (2002) Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev Biol 248:170-81
Wang, Q; Sigmund, C D; Lin, J J (2000) Identification of cis elements in the cardiac troponin T gene conferring specific expression in cardiac muscle of transgenic mice. Circ Res 86:478-84
Wang, D Z; Reiter, R S; Lin, J L et al. (1999) Requirement of a novel gene, Xin, in cardiac morphogenesis. Development 126:1281-94
Runyan, R B; Wendler, C C; Romano, L A et al. (1999) Utilization of antisense oligodeoxynucleotides with embryonic tissues in culture. Methods 18:316-21
Swiderski, R E; Reiter, R S; Nishimura, D Y et al. (1999) Expression of the Mf1 gene in developing mouse hearts: implication in the development of human congenital heart defects. Dev Dyn 216:16-27
Klewer, S E; Krob, S L; Kolker, S J et al. (1998) Expression of type VI collagen in the developing mouse heart. Dev Dyn 211:248-55
Sheffield, V C; Pierpont, M E; Nishimura, D et al. (1997) Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. Hum Mol Genet 6:117-21

Showing the most recent 10 out of 33 publications